Selected article for: "abnormal coagulation function and acute respiratory syndrome sars"
Author: Cao, Tingting; Zhang, Guqin; Xie, Huabing; Pellegrini, Emily; Li, Jin; Chen, Xiaoxing; Pan, Huaqin
Title: Case Report: The Coronavirus Disease 2019 (COVID-19) Pneumonia With Multiple Thromboembolism
  • Cord-id: 1svkabkk
  • Document date: 2021_1_12
    • ID: 1svkabkk
    Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China, in late December 2019 and has since spread rapidly around the world. Severe coronavirus disease 2019 (COVID-19) pneumonia patients have abnormal blood coagulation function, but their thromboembolism prevalence is still unknown. We reported a case of a 49-year-old man infected with COVID-19, presenting with fever, chest pain, limb weakness, myalgia, and dyspnea. The patient was diagnosed with severe COVID-19 p
    Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China, in late December 2019 and has since spread rapidly around the world. Severe coronavirus disease 2019 (COVID-19) pneumonia patients have abnormal blood coagulation function, but their thromboembolism prevalence is still unknown. We reported a case of a 49-year-old man infected with COVID-19, presenting with fever, chest pain, limb weakness, myalgia, and dyspnea. The patient was diagnosed with severe COVID-19 pneumonia, pulmonary thromboembolism (PTE), deep vein thrombosis (DVT), and cerebral infarction. He received supportive and empirical treatment including anticoagulant treatment, anti-inflammatory treatment, oxygen supply, and inhalation therapy. The patient's symptoms, CT images, and laboratory results improved after treatment, and a throat swab was reported to be negative for SARS-CoV-2 virus by polymerase chain reaction (PCR) test. However, on day 51 of illness onset, CT reexamination demonstrated hemorrhagic infarction. Anticoagulant therapy was discontinued temporarily. After the patient tested negative for SARS-CoV-2 virus by PCR test six more times, he was discharged and remained in home quarantine. This case highlights the importance of clinician attentiveness to the appearance of multiple thromboembolism, especially in patients with severe pulmonary damage. It also emphasizes the diagnostic value of early CT imaging and the need for effective treatment once thrombotic events occur.

    Search related documents:
    Co phrase search for related documents
    • active treatment and low molecular: 1, 2
    • active treatment and low molecular weight: 1, 2
    • active treatment and low molecular weight heparin: 1, 2
    • active treatment and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute sars respiratory distress syndrome and low density: 1
    • acute sars respiratory distress syndrome and low molecular: 1, 2, 3, 4, 5
    • acute sars respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5
    • acute sars respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4
    • acute sars respiratory distress syndrome and low temperature: 1
    • acute sars respiratory distress syndrome and lymphocyte count: 1, 2, 3
    • adequate thromboprophylaxis and low molecular: 1, 2
    • adequate thromboprophylaxis and low molecular weight: 1, 2
    • adequate thromboprophylaxis and low molecular weight heparin: 1, 2
    • adequate thromboprophylaxis and low molecular weight heparin anticoagulant therapy: 1
    • admission day and low density: 1, 2, 3, 4, 5, 6, 7, 8
    • admission day and low molecular: 1, 2, 3, 4, 5, 6, 7
    • admission day and low molecular weight: 1, 2, 3, 4, 5, 6, 7
    • admission day and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • admission day and low temperature: 1, 2